THERAGENICS CORP: key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2012)

$82.6M

Net Income/Loss (FY2012)

$2.1M

Total Assets (FY2012)

$105.7M

Total Equity (FY2012)

$76.9M

Cash Flows from Operating Activities (FY2012)

$13.2M

Source: THERAGENICS CORP 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.